Nirit Lev MD, PhD
Department of Neurology
Rabin Medical Center, Beilinson Campus
Nirit Lev MD, PhD
Department of Neurology
Rabin Medical Center, Beilinson Campus
EDUCATION
1990-1997 Tel Aviv University, Tel Aviv, Israel
Subject: Medicine
1998 MD degree Suma Cum Laude
Title of Doctoral Dissertation: "Prognostic significance of chest CT findings at diagnosis of Hodgkin's disease"
Supervisors: Dr Apter, Prof. Ben BasatS
MD License No. 030573
2004 Specialty: Neurology
Specialist License No. 2616
2004-2009 Tel Aviv University, Tel Aviv, Israel
Subject: Doctorate in Philosophy – Neuroscience
PhD
Title of Doctoral Dissertation: "The role of DJ-1 in neurodegenerative diseases."
Supervisors: Prof. Eldad Melamed, Prof. Daniel Offen
ACADEMIC & PROFESSIONAL ACTIVITIES & ACHIEVEMENTS
Academic Experience:
1992 Tutor, Anatomy and Dissection Course, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
1999-2004 Tutor and lecturer, Clinical Neurology Clerkships+ Neurology part of Internal Medicine clearkships, Sackler School of Medicine and NY Program, Tel Aviv University, Tel Aviv, Israel
2002-2010 Tutor to Nurses, Neurology Course, Dina Academic School of Nursing, Petach Tikva, Israel
2005-2011 Lecturer, The molecular basis of neurodegenerative diseases, The Adelson Graduate School of Medicine, Sackler School of Medicine, Tel Aviv, Israel
2008-2011 Lecturer, Clinical aspects of Biochemistry course – Four-years MD program, Sackler School of Medicine, Tel Aviv University
2010-present Tutor and lecturer, Clinical Neurology Clerkships and Internal Medicine Clerkships (neurology part), Sackler School of Medicine and NY Program, Tel Aviv University, Tel Aviv, Israel
Professional Experience:
1998 Rotating Internship, Rabin Medical Center, Beilinson Campus, Petach Tikva, Israel
1998-2004 Resident, Department of Neurology, Rabin Medical Center, Beilinson Campus, Petach Tikva, Israel
2010-present Senior Neurologist, Department of Neurology, The Movement Disorders Unit, Rabin Medical Center, Beilinson Campus, Petach Tikva, Israel
GRANTS (2008-present)
2006-2008 The Colton Foundation Scholarship for Outstanding Academic Merit, Tel Aviv University
Total Amount: $72,000.
2009-present Morasha Clinical Research Israel Science Foundation. Research grant No. 1690/09:
“DJ-1’s role in dopamine vesicular sequestration and its neuroprotective potential.”
Total Amount: $96,000.
2012 Rabin Medical Center-Bar Ilan University Joint Research Grant.
"The role of SIRT6 in Parkinson's disease."
Total Amount: $30,000.
Awards (2008-present)
2010 Distinction in preclinical teaching. Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University.
2012 Particularly noteworthy report highlighting a significant advance. The American Academy of Neurology Annual Meeting, New Orleans, USA.
2012 Best Neurological Tutor Award, Sackler School of Medicine
SCIENTIFIC PUBLICATIONS (2008-present)
ORIGINAL ARTICLES
Articles Published
12. N. Lev N, D. Ickowicz, E. Melamed, D. Offen.
Oxidative insults induce DJ-1 upregulation and redistribution: Implications for neuroprotection.
Neurotoxicology 29:397-405, 2008.
(TOXICOLOGY 22/83, IF 3.096, Cited 44)
13. N. Lev, D. Ickowicz, Y. Barhum, N. Blondheim, E. Melamed, D. Offen.
DJ-1 changes in G93A-SOD1 transgenic mice: Implications for oxidative stress in ALS.
J Mol Neurosci 38:94-102, 2009.
(NEUROSCIENCES 138/244, IF 2.504, Cited 9)
14. N. Lev, D. Ickowicz, Y. Barhum, S. Lev, E. Melamed, D. Offen.
DJ-1 protects against dopamine toxicity.
J Neural Transm 116:151-160, 2009.
(CLINICAL NEUROLOGY 72/192, IF 2.730, Cited 28)
15. N. Grünberg-Etkovitz, N. Lev, D. Ickowicz, A. Avital, D. Offen,
Z. Malik.
Accelerated proteasomal activity by Pb++, Ga+++ and Cu++ exposure does not induce aggregated α-synuclein degradation.
J Environ Pathol Toxicol Oncol 28:5-24, 2009.
(TOXICOLOGY 72/83, IF 1.000, Cited 3)
16. R. Barzilay, T. Ben-Zur, O. Sadan, Z. Bren, M. Taler, N. Lev,
I. Tarasenko, R. Uzan, I. Gil-Ad, E. Melamed, A. Weizman, D. Offen.
Intracerebral adult stem cells transplantation increases brain-derived neurotrophic factor levels and protects against phencyclidine-induced social deficit in mice.
Translational Psychiatry 2011;1:e61.
(No IF, Cited 0)
17. E. Kozela*, N. Lev*, N. Kaushansky, R. Eilam, N. Rimmerman,
R. Levy, A. Ben-Nun, A. Juknat, Z. Vogel.
Cannabidiol inhibits pathogenic T-cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in mice.
Br J Pharmacol 163:1507-1519, 2011.
*Both authors contributed equally to the manuscript.
(PHARMACOLOGY & PHARMACY 35/261, IF 4.409, Cited 5)
18. Y. Fisher-Shoval, Y. Barhum, O. Sadan, S. Yust-Katz, T. Ben-Zur,
N. Lev, C. Benkler, M. Hod, E. Melamed, D. Offen.
Transplantation of Placenta-Derived Mesenchymal Stem Cells in the EAE Mouse Model of MS.
J Mol Neurosci 48:176-184, 2012.
(NEUROSCIENCES 138/244, IF 2.504, Cited 2)
19. S. Yust-Katz, Y. Fisher-Shoval, Y. Barhum, T. Ben-Zur, R. Barzilai,
N. Lev, M. Hod, E. Melamed, D. Offen.
Placental mesenchymal stromal cells induced into neurotrophic factor-producing cells protect neuronal cells from hypoxia and oxidative stress. Cytotherapy 14:45-55, 2012.
(BIOTECHNOLOGY & APPLIED MICROBIOLOGY 33/158, IF 3.627, Cited 2)
20. N. Lev, Y. Barhum, N.S. Pilosof, D. Ickowicz, H.Y. Cohen,
E. Melamed, D. Offen.
DJ-1 protects against dopamine toxicity: implications for Parkinson's disease and aging.
J Gerontol A Biol Sci Med Sci 68:215-225, 2013.
(GERIATRICS & GERONTOLOGY 5/45, IF 4.598, Cited )
21. R. Barzilay, J. Ganz, O. Sadan, T. Ben-Zur, Z. Bren, N. Hinden,
M. Taler, N. Lev, I. Gil-Ad, A. Weizman, D. Offen.
Mesenchymal stem cells protect from sub-chronic phencyclidine insult in vivo and counteract changes in astrocyte gene expression in vitro.
Eur Neuropsychopharmacol 2012. [Epub ahead of print]
(CLINICAL NEUROLOGY 28/192, IF 4.046, Cited )
Articles Accepted
1. N. Lev, Y. Barhum, T. Ben-Zur, E. Melamed, I. Steiner, D. Offen.
Knocking out DJ-1 attenuates astrocytes neuroprotection against 6-hydroxydopamine toxicity.
J Mol Neuroscience
(NEUROSCIENCES 138/244, IF 2.504, Cited )
Articles Submitted
1. A. Raz, N. Lev, S. Orbach-Zinger, R. Djaldetti.
Perioperative treatment with intravenous amantadine in patients with Parkinson’s disease.
Clin Neuropharmacol
Articles in Preparation
1. N. Lev, Y. Barhum, I. Lotan, I. Steiner, E. Melamed, D. Offen.
DJ-1 knockout augments disease severity and shortens survival of G93A SOD1 mice.
2. N. Lev, Y. Barhum, T. Ben-Zur, E. Melamed, D. Offen.
DJ-1 based peptide as a novel neuroprotective strategy for Parkinson's disease.
review articles
Review Articles Published
6. R. Djaldetti, N. Lev, E. Melamed.
Lesions outside the CNS in Parkinson's disease.
Mov Disord 24:793-800, 2009.
(CLINICAL NEUROLOGY 24/192, IF 4.505, Cited 12)
7. J. Ganz, N. Lev, E. Melamed, D. Offen.
Cell replacement therapy for Parkinson's disease: how close are we to
the clinic?
Expert Rev Neurother 11:1325-1339, 2011.
(No IF, Cited 1)
Chapters in books
1. N. Lev, D. Offen, E. Melamed.
Toxic causes of Parkinson’s disease.
In: Handbook of Clinical Neurology: Parkinson's disease and related disorders.
Editors: W.C. Koller, E. Melamed
Elsevier, 2007.
2. N. Lev, Y. Gilgun-Sherki, D. Offen, E. Melamed.
Oxidative stress in multiple sclerosis. The role of oxidative stress in the pathogenesis of multiple sclerosis: Current state.
In: Oxidative stress and neurological disorders.
Editor: G.A. Qureshi
Elsevier, 2007.
3. D. Offen, I. Kann, N. Lev.
Parkinson’s disease: New horizons for an old disease.
In: The molecular basis for neurodegenerative diseases.
Editors: D. Offen, N. Lev.
Research Signpost, 2007.
4. N. Lev, E. Melamed, D. Offen.
Mechanisms in the pathogenesis of amyotrophic lateral sclerosis (ALS).
In: The molecular basis for neurodegenerative diseases.
Editors: D. Offen, N. Lev.
Research Signpost, 2007.
5. N. Lev, E. Melamed, D. Offen.
Multiple-system atrophy (MSA): A glial-mediated neurodegenerative disease.
In: The molecular basis for neurodegenerative diseases.
Editors: D. Offen, N. Lev.
Research Signpost, 2007.
6. J. Ganz, N. Lev, D. Offen.
Cell therapy in Parkinson's disease.
In: Stem cells and neurological disorders.
Editors: L. Lescaudron, G.L. Dunbar, J. Rossignol.
Science Publishers, Edenbridge Ltd, 2012.